SERA
Sera Prognostics IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$74.40M
P/E Ratio
—
EPS
$-0.67
Beta
0.93
52W High
$4.09
52W Low
$1.37
50-Day MA
$2.07
200-Day MA
$2.81
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Sera Prognostics Inc
Sera Prognostics Inc. is a leader in maternal-fetal health, specializing in innovative diagnostic solutions aimed at improving pregnancy outcomes. The company's flagship product, the PreTRM test, utilizes a proprietary biomarker platform to accurately assess the risk of preterm birth, facilitating timely interventions by healthcare providers. With a commitment to advancing prenatal diagnostics and enhancing maternal health, Sera is well-positioned for growth in this critical market segment. The company’s innovative approach not only addresses urgent clinical needs but also supports long-term value creation for its investors.
Fundamentals
| Revenue (TTM) | 81,000 |
| Gross Profit (TTM) | -83,000 |
| EBITDA | $-35.68M |
| Operating Margin | -89540.00% |
| Return on Equity | -51.80% |
| Return on Assets | -26.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.94 |
| Price-to-Book | 0.99 |
| Price-to-Sales (TTM) | 918.54 |
| EV/Revenue | 468.29 |
| EV/EBITDA | -0.61 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -58.30% |
| Shares Outstanding | $38.19M |
| Float | $27.57M |
| % Insiders | 11.68% |
| % Institutions | 64.40% |
Historical Volatility
HV 10-Day
31.76%
HV 20-Day
62.74%
HV 30-Day
79.68%
HV 60-Day
71.67%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($5.00 target)
3
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026